Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free SVA Stock Alerts

Sernova (SVA) Competitors

Sernova logo
C$0.16 +0.01 (+3.33%)
As of 10:30 AM Eastern
Compare

SVA vs. TH, BCT, IPA, HBP, and SCYB

Should you buy Sernova stock or one of its competitors? MarketBeat compares Sernova with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sernova include Theratechnologies (TH), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Helix BioPharma (HBP), and Scythian Biosciences (SCYB). These companies are all part of the "biotechnology" industry.

How does Sernova compare to Theratechnologies?

Theratechnologies (TSE:TH) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Theratechnologies has higher revenue and earnings than Sernova. Theratechnologies is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TheratechnologiesC$84.38M2.44-C$1.96M-C$0.19N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Theratechnologies' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Theratechnologies Neutral
Sernova Neutral

Theratechnologies has a beta of 0.256166, meaning that its stock price is 74% less volatile than the broader market. Comparatively, Sernova has a beta of -0.344488, meaning that its stock price is 134% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Theratechnologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sernova
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

0.5% of Theratechnologies shares are held by institutional investors. Comparatively, 0.0% of Sernova shares are held by institutional investors. 1.2% of Theratechnologies shares are held by company insiders. Comparatively, 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sernova has a net margin of 0.00% compared to Theratechnologies' net margin of -11.81%. Sernova's return on equity of 51.72% beat Theratechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Theratechnologies-11.81% 16.59% 5.15%
Sernova N/A 51.72%-119.26%

Summary

Theratechnologies beats Sernova on 6 of the 11 factors compared between the two stocks.

How does Sernova compare to BriaCell Therapeutics?

BriaCell Therapeutics (CVE:BCT) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Sernova's return on equity of 51.72% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BriaCell TherapeuticsN/A N/A N/A
Sernova N/A 51.72%-119.26%

In the previous week, BriaCell Therapeutics' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
BriaCell Therapeutics Neutral
Sernova Neutral

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BriaCell TherapeuticsN/AN/AN/A-C$0.38N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Summary

Sernova beats BriaCell Therapeutics on 5 of the 6 factors compared between the two stocks.

How does Sernova compare to ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies (CVE:IPA) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Sernova's return on equity of 51.72% beat ImmunoPrecise Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
ImmunoPrecise AntibodiesN/A N/A N/A
Sernova N/A 51.72%-119.26%

ImmunoPrecise Antibodies has higher revenue and earnings than Sernova. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, ImmunoPrecise Antibodies' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
ImmunoPrecise Antibodies Neutral
Sernova Neutral

Summary

Sernova beats ImmunoPrecise Antibodies on 5 of the 8 factors compared between the two stocks.

How does Sernova compare to Helix BioPharma?

Helix BioPharma (TSE:HBP) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

Helix BioPharma is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helix BioPharmaN/AN/A-C$50.55M-C$0.06N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Helix BioPharma's average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Helix BioPharma Neutral
Sernova Neutral

0.0% of Helix BioPharma shares are owned by institutional investors. Comparatively, 0.0% of Sernova shares are owned by institutional investors. 2.2% of Helix BioPharma shares are owned by insiders. Comparatively, 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Helix BioPharma has a beta of 0.421776, meaning that its stock price is 58% less volatile than the broader market. Comparatively, Sernova has a beta of -0.344488, meaning that its stock price is 134% less volatile than the broader market.

Sernova's return on equity of 51.72% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Helix BioPharmaN/A -36.79% -279.98%
Sernova N/A 51.72%-119.26%

Summary

Sernova beats Helix BioPharma on 7 of the 8 factors compared between the two stocks.

How does Sernova compare to Scythian Biosciences?

Scythian Biosciences (CVE:SCYB) and Sernova (TSE:SVA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scythian BiosciencesN/AN/AN/AN/AN/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Scythian Biosciences' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Scythian Biosciences Neutral
Sernova Neutral

Sernova's return on equity of 51.72% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Scythian BiosciencesN/A N/A N/A
Sernova N/A 51.72%-119.26%

Summary

Sernova beats Scythian Biosciences on 3 of the 4 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

Export
MetricSernovaBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$53.90MC$441.97MC$6.49BC$12.01B
Dividend Yield7.86%3.86%2.67%6.20%
P/E Ratio-3.883.2124.6836.69
Price / SalesN/A6,413.83476.9210.09
Price / Cash6.1513.1343.0582.29
Price / Book-2.0485.9610.404.37
Net Income-C$35.70M-C$96.07MC$3.56BC$299.09M
7 Day PerformanceN/A-2.81%-2.69%-3.28%
1 Month Performance-3.13%-0.91%-0.09%-2.58%
1 Year Performance-6.06%48.05%20.93%39.57%

Sernova Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.16
+3.3%		N/A-9.1%C$53.90MN/AN/A1,959
TH
Theratechnologies
N/AC$4.47
-4.9%		N/A+27.0%C$205.53MC$84.38MN/A103
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%		N/A+0.0%C$168.68MN/AN/A5
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%		N/A+0.0%C$162.08MC$19.47MN/A80
HBP
Helix BioPharma
N/AC$1.58
+1.3%		N/A+63.4%C$120.68MN/AN/A9

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:SVA) was last updated on 6/11/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel